Quantum Rare Earth Developments Welcomes Former Molycorp CEO To Its Advisory Board; Announces Name Change
Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake